VistaGen Therapeutics
VTGN
#10044
Rank
โ‚ฌ20.97 M
Marketcap
0,53ย โ‚ฌ
Share price
0.29%
Change (1 day)
-78.39%
Change (1 year)

Market capitalization of VistaGen Therapeutics (VTGN)

Market cap: โ‚ฌ20.97 Million

As of March 2026 VistaGen Therapeutics has a market cap of โ‚ฌ20.97 Million. This makes VistaGen Therapeutics the world's 10044th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of VistaGen Therapeutics from 2011 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ20.97 M-14.36%
2025โ‚ฌ24.48 M-64.39%
2024โ‚ฌ68.76 M-45.27%
2023โ‚ฌ0.12 B532.64%
2022โ‚ฌ19.86 M-94.22%
2021โ‚ฌ0.34 B58.95%
2020โ‚ฌ0.21 B712.93%
2019โ‚ฌ26.61 M-34.65%
2018โ‚ฌ40.72 M100.85%
2017โ‚ฌ20.27 M-31.77%
2016โ‚ฌ29.71 M80.49%
2015โ‚ฌ16.46 M77.77%
2014โ‚ฌ9.26 M34.86%
2013โ‚ฌ6.86 M-35.69%
2012โ‚ฌ10.67 M-71.71%
2011โ‚ฌ37.75 M

End of Day market cap according to different sources

On Mar 9th, 2026 the market cap of VistaGen Therapeutics was reported to be:

โ‚ฌ20.91 Million
by Nasdaq info icon info icon
โ‚ฌ20.91 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
โ‚ฌ1.20 B 5,629.20%๐Ÿ‡บ๐Ÿ‡ธ USA